Shandong Weigao Blood Purification Products Co. Ltd. logo

Shandong Weigao Blood Purification Products Co. Ltd. (603014)

Market Open
10 Aug, 06:57
SSE SSE
¥
33. 86
-0.33
-0.9652%
¥
14.75B Market Cap
- P/E Ratio
0.16% Div Yield
2.64M Volume
- Eps
¥ 34.19
Previous Close
Add Transaction
Day Range
33.73 34.34
Year Range
29.7 49.01
Want to track 603014 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

603014 trading today lower at ¥33.86, a decrease of -0.9652% from yesterday's close, completing a monthly increase of 0.4748% or ¥0.16. Over the past 12 months, 603014 stock lost -14.9032%.
603014 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

603014 Chart

Shandong Weigao Blood Purification Products Co. Ltd. (603014) FAQ

What is the stock price today?

The current price is ¥33.86.

On which exchange is it traded?

Shandong Weigao Blood Purification Products Co. Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 603014.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.16%.

What is its market cap?

As of today, the market cap is 14.75B.

Has Shandong Weigao Blood Purification Products Co. Ltd. ever had a stock split?

No, there has never been a stock split.

Shandong Weigao Blood Purification Products Co. Ltd. Profile

- Industry
- Sector
- CEO
SSE Exchange
CNE100007093 ISIN
China Country
3,734 Employees
1 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

Shandong Weigao Blood Purification Products Co. Ltd. is a prominent medical technology company that specializes in blood purification solutions. Founded in 2004 and located in Weihai, Shandong Province, the company has established itself as a leader in the domestic industry, boasting independent core technologies in blood purification. The firm is dedicated to the research, development, production, and sales of a comprehensive range of products tailored for hemodialysis and peritoneal dialysis. Through relentless investment in R&D and strategic partnerships with esteemed international firms such as Terumo and NIKKISO, Shandong Weigao has developed a vertically integrated supply chain that effectively manages all aspects of blood purification treatments. The company's efforts are significantly directed toward supporting hospitals and healthcare professionals in the management of kidney diseases, enhancing the quality of life for patients both in China and internationally. Its steadfast commitment to quality and innovation solidifies its position as a fundamental player in the medical devices and health technology market.

Products and Services

  • Dialyzers: These are critical components used to filter waste, excess fluid, and toxins from the blood in patients undergoing hemodialysis. Shandong Weigao's dialyzers are designed for efficiency and reliability, ensuring effective treatment outcomes.
  • Dialysis Machines: The company's dialysis machines are engineered to provide safe and effective treatment for patients. They integrate advanced technology for monitoring and managing the dialysis process, enhancing patient comfort and treatment precision.
  • Bloodlines: Shandong Weigao manufactures specialized bloodlines that connect patients to dialyzers and dialysis machines. These bloodlines are constructed to ensure accurate blood flow and minimize complications during dialysis sessions.
  • Peritoneal Dialysis Solutions: The company offers a comprehensive range of peritoneal dialysis solutions designed to facilitate effective kidney function management at home. These solutions allow patients more flexibility and independence while ensuring quality care.
  • Research and Development: Shandong Weigao emphasizes continuous innovation through its significant investment in research and development, focused on advancing blood purification technologies and improving patient care outcomes.
  • Collaboration with International Enterprises: The company engages in strategic collaborations with global medical organizations, fostering knowledge exchange and innovation that enhances its product offerings and service delivery.
  • Training and Support Services: Shandong Weigao provides extensive training and support for healthcare professionals, ensuring they are equipped to utilize its products optimally and provide high-quality care to kidney patients.

Contact Information

Address: No. 7, Weigao West Road
Phone: 86 63 1571 6143